On September 15, 2012 Lundbeck reported that Treanda is approved in Canada in patients with symptomatic chronic lymphocytic leukemia (CLL) who have received no prior treatment and in relapsed indolent B-cell non-Hodgkin lymphoma (iNHL) who did not respond to or progressed during or shortly following treatment with a rituximab regimen (Press release Lundbeck, SEP 13, 2012, View Source [SID:1234500349]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!